Combination therapy with medical gases (nitric oxide and molecular hydrogen): safety assessment

Q4 Medicine
D. D. Pozdnyakova, I. A. Baranova, V. D. Selemir, A. G. Chuchalin
{"title":"Combination therapy with medical gases (nitric oxide and molecular hydrogen): safety assessment","authors":"D. D. Pozdnyakova, I. A. Baranova, V. D. Selemir, A. G. Chuchalin","doi":"10.18093/0869-0189-2024-34-1-42-49","DOIUrl":null,"url":null,"abstract":"Inhaled nitric oxide (NO) and molecular hydrogen (iH2) are actively studied nowadays. The therapeutic algorithms for their use in the various conditions are being developed, but the combined use of these medical gases (MG) has not been studied well enough.The aim of the study was to assess the safety of iNO and iH2 combination in healthy volunteers.Methods. 10 healthy volunteers (4 males and 6 females), mean age 24.0 ± 1.3 years, were included in the open non-comparative prospective study. All volunteers received a single combined inhalation of NO and H2 for 90 minutes. The NO concentration was 60 ppm and the H2 concentration did not exceed 4% in the gas mixture. Changes in the vital signs, arterial blood gases, and hemodynamic parameters were evaluated. The hemodynamic parameters were investigated before and after inhalation using echocardiography (Vivid E9 General Electric, USA). We also assessed the microcirculation of the bulbar conjunctiva (“OKO” capillaroscope), the main functional lung parameters, and the diffusion lung capacity (GANSHORN PowerCube Body apparatus). The clinical side effects were recorded. After inhalation, the serum concentration of methemoglobin was evaluated.Results. When comparing the results before and after MG inhalation, there was no negative impact on the vital signs, arterial blood gases (РaO2, РaСO2, SаO2), the functional lung volumes (FEV1, FVC, FEV1 / FVC), the diffusion test parameters, main EchoCG hemodynamic data (ejection fraction, tricuspid annular plane systolic excursion (TAPSE), mean pulmonary artery pressure, left and right ventricular sizes) (p > 0,05). After inhalation, the microcirculatory parameters (the volume velocity in arterioles and venules and the arteriolar diameter) increased significantly (p < 0.05). We did not observe the increase in serum methemoglobin concentration (0.59 ± 0.11%). No clinical side effects were reported during the study.Conclusions. Combined use of inhaled NO / H2 is clinically safe, does not have any negative impact on hemodynamic parameters, functional lung volumes, and arterial blood gases. The improvement of the microcirculation was noted after a single inhalation. This new method can be recommended for further studies of the therapeutic effect in various conditions.","PeriodicalId":37383,"journal":{"name":"Pulmonologiya","volume":"20 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pulmonologiya","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18093/0869-0189-2024-34-1-42-49","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Inhaled nitric oxide (NO) and molecular hydrogen (iH2) are actively studied nowadays. The therapeutic algorithms for their use in the various conditions are being developed, but the combined use of these medical gases (MG) has not been studied well enough.The aim of the study was to assess the safety of iNO and iH2 combination in healthy volunteers.Methods. 10 healthy volunteers (4 males and 6 females), mean age 24.0 ± 1.3 years, were included in the open non-comparative prospective study. All volunteers received a single combined inhalation of NO and H2 for 90 minutes. The NO concentration was 60 ppm and the H2 concentration did not exceed 4% in the gas mixture. Changes in the vital signs, arterial blood gases, and hemodynamic parameters were evaluated. The hemodynamic parameters were investigated before and after inhalation using echocardiography (Vivid E9 General Electric, USA). We also assessed the microcirculation of the bulbar conjunctiva (“OKO” capillaroscope), the main functional lung parameters, and the diffusion lung capacity (GANSHORN PowerCube Body apparatus). The clinical side effects were recorded. After inhalation, the serum concentration of methemoglobin was evaluated.Results. When comparing the results before and after MG inhalation, there was no negative impact on the vital signs, arterial blood gases (РaO2, РaСO2, SаO2), the functional lung volumes (FEV1, FVC, FEV1 / FVC), the diffusion test parameters, main EchoCG hemodynamic data (ejection fraction, tricuspid annular plane systolic excursion (TAPSE), mean pulmonary artery pressure, left and right ventricular sizes) (p > 0,05). After inhalation, the microcirculatory parameters (the volume velocity in arterioles and venules and the arteriolar diameter) increased significantly (p < 0.05). We did not observe the increase in serum methemoglobin concentration (0.59 ± 0.11%). No clinical side effects were reported during the study.Conclusions. Combined use of inhaled NO / H2 is clinically safe, does not have any negative impact on hemodynamic parameters, functional lung volumes, and arterial blood gases. The improvement of the microcirculation was noted after a single inhalation. This new method can be recommended for further studies of the therapeutic effect in various conditions.
医用气体(一氧化氮和分子氢)联合疗法:安全性评估
如今,人们正在积极研究吸入一氧化氮(NO)和分子氢(iH2)。本研究的目的是评估一氧化氮和 iH2 在健康志愿者中联合使用的安全性。这项开放式非比较前瞻性研究共纳入了 10 名健康志愿者(4 男 6 女),平均年龄为 24.0 ± 1.3 岁。所有志愿者都接受了一次为期 90 分钟的 NO 和 H2 联合吸入。混合气体中的 NO 浓度为 60 ppm,H2 浓度不超过 4%。对生命体征、动脉血气和血液动力学参数的变化进行了评估。使用超声心动图(美国通用电气公司的 Vivid E9)对吸入前后的血液动力学参数进行了调查。我们还评估了球结膜的微循环("OKO "毛细血管镜)、主要肺功能参数和扩散肺活量(GANSHORN PowerCube Body 仪器)。记录了临床副作用。吸入后,评估血清中高铁血红蛋白的浓度。对比吸入 MG 前后的结果,生命体征、动脉血气(РaO2、РaСO2、SаO2)、肺功能容积(FEV1、FVC、FEV1/FVC)均无不良影响、扩散试验参数、EchoCG 主要血液动力学数据(射血分数、三尖瓣环面收缩期偏移(TAPSE)、平均肺动脉压、左心室和右心室大小)(P > 0.05)。吸入后,微循环参数(动静脉容积速度和动静脉直径)显著增加(P < 0.05)。我们没有观察到血清高铁血红蛋白浓度的增加(0.59 ± 0.11%)。研究期间未发现任何临床副作用。联合使用吸入式 NO / H2 在临床上是安全的,不会对血液动力学参数、肺功能容积和动脉血气产生任何负面影响。单次吸入后,微循环明显改善。建议进一步研究这种新方法在各种情况下的治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pulmonologiya
Pulmonologiya Medicine-Pulmonary and Respiratory Medicine
CiteScore
1.40
自引率
0.00%
发文量
70
期刊介绍: The aim of this journal is to state a scientific position of the Russian Respiratory Society (RRS) on diagnosis and treatment of respiratory diseases based on recent evidence-based clinical trial publications and international consensuses. The most important tasks of the journal are: -improvement proficiency qualifications of respiratory specialists; -education in pulmonology; -prompt publication of original studies on diagnosis and treatment of respiratory diseases; -sharing clinical experience and information about pulmonology service organization in different regions of Russia; -information on current protocols, standards and recommendations of international respiratory societies; -discussion and consequent publication Russian consensus documents and announcement of RRS activities; -publication and comments of regulatory documents of Russian Ministry of Health; -historical review of Russian pulmonology development. The scientific concept of the journal includes publication of current evidence-based studies on respiratory medicine and their discussion with the participation of Russian and foreign experts and development of national consensus documents on respiratory medicine. Russian and foreign respiratory specialists including pneumologists, TB specialists, thoracic surgeons, allergists, clinical immunologists, pediatricians, oncologists, physiologists, and therapeutists are invited to publish article in the journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信